Bird flu vaccine timing tested: is 3 weeks or 8 weeks better?
NCT ID NCT07275060
Summary
This study is testing whether spacing two doses of an approved H5N1 bird flu vaccine 8 weeks apart works as well as the standard 3-week spacing. Researchers are comparing the immune response and safety in 312 healthy adults aged 18-59. The goal is to gather more data on how timing affects protection against this specific strain of avian influenza.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AVIAN INFLUENZA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU de Québec
Québec, Quebec, G1E 7G9, Canada
-
Canadian Center for Vaccinology
Halifax, Nova Scotia, Canada
-
Vaccine Evaluation Center
Vancouver, British Columbia, Canada
-
Vaccine Study Centre of the McGill University Health Centre
Pierrefonds, Quebec, H9H 4Y6, Canada
Conditions
Explore the condition pages connected to this study.